Cornercap Investment Counsel’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,458
| Closed | -$48.9K | – | 484 |
|
|
2024
Q3 | $48.9K | Sell |
41,458
-39,133
| -49% | -$46.2K | 0.01% | 509 |
|
|
2024
Q2 | $98.3K | Sell |
80,591
-761
| -0.9% | -$928 | 0.02% | 571 |
|
|
2024
Q1 | $177K | Hold |
81,352
| – | – | 0.03% | 575 |
|
|
2023
Q4 | $126K | Hold |
81,352
| – | – | 0.02% | 556 |
|
|
2023
Q3 | $105K | Sell |
81,352
-1,063
| -1% | -$1.37K | 0.02% | 534 |
|
|
2023
Q2 | $142K | Hold |
82,415
| – | – | 0.02% | 538 |
|
|
2023
Q1 | $124K | Sell |
82,415
-65,939
| -44% | -$99.6K | 0.02% | 533 |
|
|
2022
Q4 | $237K | Hold |
148,354
| – | – | 0.04% | 496 |
|
|
2022
Q3 | $215K | Buy |
148,354
+69,902
| +89% | +$101K | 0.04% | 485 |
|
|
2022
Q2 | $144K | Buy |
+78,452
| New | +$144K | 0.03% | 508 |
|